Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
deals
fda
life sciences
national blog main
new york blog main
2
×
the medicines company
achaogen
adams street partners
alirocumab
alnylam pharmaceuticals
amgen
antibiotics
beta lactamase inhibitor
biomedical advanced research and development authority (barda)
boston blog main
boston top stories
drug resistance
drugs
evolocumab
hatteras venture partners
inclisiran
investing
lyzz capital
macrolide pharmaceuticals
melinta therapeutics
meropenem
michael dudley
national top stories
new enterprise associates
new york
new york top stories
novartis
pcsk9
pcsk9 inhibitors
regeneron pharmaceuticals
rempex pharmaceuticals
rna interference
san diego
What
company
2
×
drug
medicines
2
×
acquire
agreed
bacteria
billion
biopharma
brings
business
cash
cholesterol
compound
deal
disease
exited
fda
fighting
infections
infectious
launches
medco
melinta
new
novartis
poised
products
qpex
ready
resistant
sold
tackle
therapeutics
wave
year
Language
unset
Current search:
medicines
×
company
×
" new york blog main "
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections